Cigna Launches AI-Powered Platform to Speed Specialty Prescriptions

Cigna (NYSE: UNH), through its pharmacy services arm Evernorth, has launched a new digital platform called Pharmacy Forward, powered by artificial intelligence to speed up the processing of specialty prescriptions and reduce delays. The initiative comes with a $100 million investment as part of the company's effort to improve pharmaceutical supply chain efficiency.

The Product — What Sets It Apart

Pharmacy Forward automates many manual steps in specialty prescription processing, such as verifying insurance coverage and obtaining prior authorizations. The platform uses machine learning algorithms to analyze patient and prescription data, allowing it to prioritize dispensing and reduce wait times. According to Evernorth, the platform can cut prescription processing time by up to 50% in some cases.

Pricing and Availability

Cigna has not disclosed standalone pricing for the platform, but it is expected to be available to Evernorth's existing clients—insurers and employers—as part of current service contracts. The platform will be rolled out gradually over the current year.

Competition

Pharmacy Forward faces competition from similar solutions offered by CVS Health (through its Caremark platform) and UnitedHealth Group (through OptumRx). Additionally, startups like GoodRx and Amazon's PillPack provide digital services in this space. However, Cigna's focus on high-cost specialty prescriptions could give it a competitive edge.

Potential Impact on the Company

The new platform is expected to strengthen Evernorth's position in the pharmacy benefit management (PBM) market, particularly in the fast-growing specialty drug segment. It may also improve customer satisfaction and reduce operational costs, positively impacting Cigna's long-term profitability.